Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196288 | 1.00 | KMT2A (0.38) | KMT2APOLBL3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL26372509 | 0.89 | KMT2A (0.33) | KMT2APOLBL3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL1931813 | 0.89 | KMT2A (0.38) | KMT2APOLBL3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL23795575 | 0.89 | SMN1; SMN2 (0.35) | KMT2APOLBL3MBTL1SMN1; SMN2CAD | |
| SCHEMBL1931815 | 0.89 | KMT2A (0.38) | KMT2APOLBL3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL1930728 | 0.87 | KMT2A (0.38) | KMT2APOLBL3MBTL1ALDH1A1CYP3A4 | |
| SCHEMBL24638654 | 0.87 | KMT2A (0.32) | KMT2APOLBL3MBTL1 | |
| SCHEMBL26372507 | 0.86 | KMT2A (0.32) | KMT2APOLBL3MBTL1 | |
| SCHEMBL26372504 | 0.86 | KMT2A (0.32) | KMT2APOLBL3MBTL1 | |
| SCHEMBL7065761 | 0.85 | MAPT (0.35) | L3MBTL1ALDH1A1HSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540211-B2 | Composition and process for producing silylated polymers and use thereof | POLYU GMBH (DE) | 2026-02-03 | — | — | US | claimed |
| EP-3976680-B1 | TWO-COMPONENT COMPOSITION HAVING HIGH STRENGTH | SIKA TECH AG (CH) | 2025-11-26 | — | — | EP | claimed |
| EP-4196513-A1 | SELECTIVE POLYURETHANE PREPOLYMER SYNTHESIS | PolyU GmbH (DE) | 2023-06-21 | — | — | EP | claimed |
| US-20220372285-A1 | SELECTIVE POLYURETHANE PREPOLYMER SYNTHESIS | POLYU GMBH (DE) | 2022-11-24 | — | — | US | claimed |
| US-20220259365-A1 | COMPOSITION AND PROCESS FOR PRODUCING SILYLATED POLYMERS AND USE THEREOF | POLYU GMBH (DE) | 2022-08-18 | — | — | US | claimed |
| US-20220235171-A1 | COMPOSITION AND PROCESS FOR PREPARING MOISTURE-CROSSLINKING POLYMERS AND USE THEREOF | POLYU GMBH (DE) | 2022-07-28 | — | — | US | claimed |
| US-20220235169-A1 | METAL-SILOXANE-SILANOL(ATE) COMPOUND AS GEL CATALYST | POLYU GMBH (DE) | 2022-07-28 | — | — | US | claimed |
| EP-3976680-A1 | TWO-COMPONENT COMPOSITION WITH A HIGH DEGREE OF STRENGTH | Sika Technology AG (CH) | 2022-04-06 | — | — | EP | claimed |
| EP-3947498-A1 | COMPOSITION AND PROCESS FOR PREPARING MOISTURE CROSS-LINKED POLYMERS, AND USE THEREOF | PolyU GmbH (DE) | 2022-02-09 | — | — | EP | claimed |
| CN-113631606-A | Compositions and methods for preparing silylated polymers and uses thereof | 波利有限公司 | 2021-11-09 | — | — | CN | claimed |
| EP-2970716-A1 | FAST CURE ASPARTATE POLYSILOXANE HYBRID COATING | Covestro LLC (US) | 2016-01-20 | — | — | EP | claimed |
| US-20150291846-A1 | Fast Cure Aspartate Polysiloxane Hybrid Coating | COVESTRO LLC | 2015-10-15 | — | — | US | claimed |
| US-9085712-B2 | Fast cure aspartate polysiloxane hybrid coating | BAYER MATERIALSCIENCE LLC (US) | 2015-07-21 | — | — | US | claimed |
| WO-2014159307-A1 | FAST CURE ASPARTATE POLYSILOXANE HYBRID COATING | BAYER MATERIALSCIENCE LLC (US) | 2014-10-02 | — | — | WO | claimed |
| US-20140272424-A1 | FAST CURE ASPARTATE POLYSILOXANE HYBRID COATING | COVESTRO LLC | 2014-09-18 | — | — | US | claimed |
| CN-102186895-B | Polyurethane composition containing organomethoxysilane having anisotropic properties | SIKA TECHNOLOGY AG | 2013-08-21 | — | — | CN | claimed |
| US-8404077-B2 | Polyurethane composition that contains organomethoxysilane and has anisotropic material properties | SIKA TECHNOLOGY AG (CH) | 2013-03-26 | — | — | US | claimed |
| CN-102186895-A | Polyurethane composition containing organomethoxysilane having anisotropic properties | SIKA TECHNOLOGY AG | 2011-09-14 | — | — | CN | claimed |
| US-20110198031-A1 | POLYURETHANE COMPOSITION THAT CONTAINS ORGANOMETHOXYSILANE AND HAS ANISOTROPIC MATERIAL PROPERTIES | SIKA TECHNOLOGHY AG (CH) | 2011-08-18 | — | — | US | claimed |
| EP-2189484-B1 | Polyurethane composition comprising organomethoxysilane having anisostropic material properties | SIKA TECHNOLOGY AG (CH) | 2011-05-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540211-B2 | Composition and process for producing silylated polymers and use thereof | EPCAM, ITGB1, TMSB10 | KMT2A 2041/4885POLB 1123/4885L3MBTL1 2206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.